Initial Statement of Beneficial Ownership (3)
07 Januar 2021 - 10:56PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Li Dean Y |
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2021
|
3. Issuer Name and Ticker or Trading Symbol
Merck & Co., Inc. [MRK]
|
(Last)
(First)
(Middle)
MERCK & CO., INC., 2000 GALLOPING HILL ROAD |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Executive VP & President, MRL / |
(Street)
KENILWORTH, NJ 07033
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 7170.093 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Restricted Stock Unit | 5/4/2019 (2) | 5/4/2021 | Common Stock | 694 | (3) | D | |
Restricted Stock Unit | 5/3/2020 (4) | 5/3/2022 | Common Stock | 1500 | (3) | D | |
Restricted Stock Unit | 5/1/2021 (5) | 5/1/2023 | Common Stock | 3090 | (3) | D | |
Stock Option (Right to Buy) | 5/5/2018 (6) | 5/4/2027 | Common Stock | 14265 | $63.97 | D | |
Stock Option (Right to Buy) | 5/4/2019 (7) | 5/3/2028 | Common Stock | 14638 | $57.75 | D | |
Stock Option (Right to Buy) | 5/3/2020 (8) | 5/2/2029 | Common Stock | 16936 | $80.00 | D | |
Stock Option (Right to Buy) | 5/1/2021 (9) | 4/30/2030 | Common Stock | 24165 | $77.67 | D | |
Explanation of Responses: |
(1) | Holdings include shares acquired in dividend reinvestment transactions. |
(2) | These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. |
(3) | Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. |
(4) | These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. |
(5) | These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. |
(6) | The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020. |
(7) | The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. |
(8) | The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. |
(9) | The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. |
Remarks: See Exhibit 24 - Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Li Dean Y MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH, NJ 07033 |
|
| Executive VP & President, MRL |
|
Signatures
|
/s/ Kelly Grez as Attorney-in-Fact for Dean Y. Li | | 1/7/2021 |
**Signature of Reporting Person | Date |
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024